Fintel PLC - Issues of Shares

Fintel plc

(the "Company" or "Fintel")

Issue of Shares

Fintel plc (AIM: FNTL) announces that it has issued 211,190 ordinary shares of £0.01 each to satisfy certain share entitlements of members who have elected to exercise their options pursuant to the Company Share Option Plan (CSOP) and the Unapproved Company Share Option Plan (NTA) .

Application has been made for the 211,190 newly issued shares to be admitted to trading on AIM, and admission is expected to take place on 27 May 2021 ("Admission"). Following Admission, the Company's issued share capital will consist of 97,017,802 ordinary shares. There are no ordinary shares held in treasury. Therefore, following Admission, this figure of 97,017,802 should be used by shareholders as the denominator for the calculation by which they determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Fintel plc Matt Timmins (Joint Chief Executive Officer) Neil Stevens (Joint Chief Executive Officer)	via Instinctif Partners
Zeus Capital (Nominated Adviser and Joint Broker) Martin Green Dan Bate Pippa Hamnett	+44 (0) 20 3829 5000
Liberum (Joint Broker) Cameron Duncan James Greenwood Ed Phillips	+44 (0) 20 3100 2222
Instinctif Partners (Financial PR) Mark Walter Lewis Hill	+44 (0) 78 3767 4600 Fintel@instinctif.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END